Dinoy, Jeralyen M.

HRN: 28-63-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CO-AMOXICLAV 625MG (TAB)
04/17/2026
04/23/2026
PO
625mg
Q8h
SP NSVD Thinly Msaf
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: